key: cord-0893375-p6bxpmy6 authors: Murthy, T. P. Krishna; Joshi, Trupthi; Gunnan, Shivani; Kulkarni, Nidhi; V, Priyanka; Kumar, S. Birendra; Gowrishankar, B. S. title: In silico analysis of Phyllanthus amarus phytochemicals as potent drugs against SARS-CoV-2 main protease date: 2021-08-14 journal: Current Research in Green and Sustainable Chemistry DOI: 10.1016/j.crgsc.2021.100159 sha: ade6c0e7901ca3270ca1452e9f5125ab4bba7af7 doc_id: 893375 cord_uid: p6bxpmy6 Phyllanthus amarus, also known as Bhui Korma in India, is well known for its medicinal properties and is used to treat several diseases worldwide. This study aims to identify phytochemicals from P. amarus and assess their anti-viral activity through in silico methods against the main protease (MPro) enzyme of the novel coronavirus. 190 compounds were obtained from literature and docked against 3CLPro and 16 compounds showed great binding affinity with 3CLPro with their values lying between -8.9 kcal/mol to -9.6 kcal/mol. The top two compounds, Myricitrin (CID: 5352000) and Quercetin-3-O-glucuronide (CID: 12004528) gave high binding affinity values of -9.6 kcal/mol and -9.4 kcal/mol respectively and also display favourable binding interactions with the MPro. Both the compounds were further subjected to molecular dynamics simulation and MM-PBSA based binding free energy calculations. ADMET and drug-likeness properties were studied to assess the pharmacokinetic properties of the compounds. Favourable pharmacokinetic results reinforced the applicability of the compounds assessed. Along with continuous studies being carried out with chemical compounds, research needs to expand into all areas, including the use of natural compounds as drug compounds. The identified hits from this study can be taken further for in vitro and in vivo studies to examine their efficacy against COVID-19. The entire world has come to a standstill with the emergence of the COVID-19 pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (Sanders et al. 2020 ). Coronaviruses, (CoV) Stoneman 2020). While the first four strains were self-limiting and only caused mild diseases, the last two were highly contagious leading to community outbreaks and caused fatal respiratory infections (Ghosh et al. 2020) . (Dong, Du, and Gardner 2020) . SARS-CoV-2, like all coronaviruses, is an enveloped, single-stranded, positive sense, RNA virus. The genome sequence of the virus shows that it is about 30,000 bp long with 10 open reading frames (ORFs) (Wu et al. 2020 ) and, it encodes several structural proteins, nonstructural proteins and viral accessory proteins. The structural proteins include (1) spike (S) protein, (2) membrane envelope (M) protein, (3) nucleo-capsid (N) protein, and (4) envelope (E) protein (Gil et al. 2020) . This virus, like other viruses of this family, has 16 non-structural proteins (nsps). The non-structural proteins whose structures are available so far are the main protease (3CLpro, nsp5) (L. , the papain-like protease (PLpro, nsp3), the RNA-dependent RNA polymerase (RdRp, nsp12) (Gao et al. 2020) in complex with cofactors nsp7 and nsp8, the methyltransferase-stimulatory factor complex of nsp16 and nsp10, the J o u r n a l P r e -p r o o f complex nsp10-nsp16, the nsp9-binding protein, and the nsp15 endoribonuclease (Gil et al. 2020 ). The main protease, in particular, plays a fundamental role in the polyprotein processing of the two replicase polyproteins, pp1a and pp1ab. RdRp and nsp13 cannot function properly without prior proteolytic release, making M pro a key enzyme in the replication cycle (Du et al. 2004; Hegyi and Ziebuhr 2002) . Due to structural and sequential similarity of the main proteases with other closely related betacoronaviruses, a good foundation for drug discovery has already been laid down (Jaimes et al. 2020; Naqvi et al. 2020) In addition to all this, the dissimilarity between SARS-CoV2 M pro and human proteases has resulted in us choosing M pro as our target for this study (Ullrich and Nitsche 2020) . Efforts have been made to repurpose drugs that have been used for the treatment of Ebola virus (EBOV), influenza virus (IFV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) (Gil et al. 2020) to effectively treat SARS-CoV-2, using experimental, clinical-based or computational methods (Dhir et al. 2020) . RNA polymerase inhibitor-remdesivir, 3CL protease inhibitors-lopinavir/ritonavir, and ivermectin, PL protease inhibitor-disulfiram, and a drug that interferes with the acidification of the endosome-hydroxychloroquine is such examples of repurposed drugs that have entered clinical trials (Gil et al. 2020 ). However, it has been shown that there is no particular pharmaceutical formulation that can cure a person infected with COVID-19 (Cao et al. 2020; Sanders et al. 2020; Wang et al. 2020) . In light of this, many researchers have moved towards looking for answers in natural products. Azadirachta indica (Parida et al. 2002) , Lycoris radiate (Li et al. 2005) , Withania somnifera, Phyllanthus urinaria (Yang et al. 2007) , Glycyrrhiza glabra, Ocimum species , Allium sativum (Mukhtar et al. 2008) , and many other species have been used for centuries around the world for the treatment of fever, cough and cold and have also shown certain antiviral properties which opens opportunities to explore their applications in drug design. Phyllanthus amarus goes by the name sleeping plant or Bhui korma in India (Janghel, Patel, and Chandel 2019) . It belongs to the Euphorbiaceae family and is a small medicinal herb that is used throughout the world for multiple ailments. It is also an important plant in Indian traditional medicine (Patel et al. 2011) , African traditional medicine (Ekor 2014) , and Chinese traditional medicine ,in which it is used for the treatment of digestive disease, jaundice, and renal calculus (Mao et al. 2016) . The compounds extracted from this plant have J o u r n a l P r e -p r o o f hepatoprotective (Xavier et al. 2012) , nephroprotective (Bakhtiary et al. 2012) , antibacterial (Dhandapani et al. 2007) , antiviral (Mukhtar et al. 2008 ), antiplasmodial (Appiah-Opong et al. 2011 , antinflammatory (Harikrishnan et al. 2018) , antidiabetic (Shetti, Sanakal, and Kaliwal 2015) , antimalarial (Ojezele, Moke, and Onyesom 2017) , anticancer (Ramsewak et al. 2002) , and antioxidant (Lim and Murtijaya 2007) properties in humans. Different parts of the Phyllanthus amarus plant are rich in phytochemicals like alkaloids, flavonoids(J. Meena* 2018) , lignans (Sarin et al. 2014) , tannins (Patel et al. 2011) , sterols (Mao et al. 2016) , tetraterpenes (Zubair et al. 2017 ) and many other compounds. Phyllanthus amarus has shown promising anti-viral activity which is attributed to the various tests conducted by in vivo and in silico tools, which showed positive results against Hepatitis B virus (HBV) (C. D. Lee et al. 1996) , WoodChuck Hepatitis Virus (WHV) (Venkateswaran, Millman, and Blumberg 1987) , R5 pseudotype HIV virus (Sagar et al. 2004) , Hepatitis-C virus (Nikam et al. 2011) , Dengue Virus-2, Cytomegalovirus and Sindbis, Rous-sarcoma and the Maloney-leukaemia virus (Moshi et al. 2008 ). Thus, Phyllanthus amarus, with its multiple antimicrobial and antiviral phytochemicals could be a plausible candidate in the search for a drug for COVID-19. Compounds can be identified through in silico virtual screening and further studying the docking interactions, ADME and toxicity profiles of these extracts could shine a light on whether compounds from Phyllanthus amarus could target SARS-CoV-2. (Berman et al. 2000) in the .pdb format. J o u r n a l P r e -p r o o f BIOVIA Discovery studio visualizer software was used to combine all the ligands into a single file and was saved in the .sdf format. After downloading the protein in PDB format, Swiss PDB Viewer was used to delete the non-amino acid residues to make the receptor free of any ligands before docking (Guex and Peitsch 1997) . The Graphical User Interface program ''AutoDock Tools'' (Morris et al. 2009 ) was used to prepare the protein file. Water was deleted and Kollman united atom charges were added; solvation parameters and polar hydrogens were added to the receptor for the preparation of protein which was then saved in. pdbqt format. AutoDock Vina docking engine was used on the PyRx platform (Dallakyan and Olson 2015) . The combined ligand file (.sdf) was imported on PyRx as a Chemical Table SDF file. The energy of the molecules was minimized using OpenBabel on PyRx following which they were converted to AutoDock Ligand format (. pdbqt). After the protein was imported, docking was performed on Vina Wizard for each of the ligands. AutoDock Vina requires a grid box to be set which defines the search space in the protein. This grid box must surround the region of interest (active site) in the macromolecule. Literature review, along with the structure visualization feature on PDB, allowed us to identify the active sites of the protein. In 3ClPro, a major region of interest is the Cys-His catalytic dyad, made up of His41 and Cys145 (Jin et al. 2020) . The grid was placed such that the amino acids involved in catalytic activity along with the other active site residues were selected (Table 1) . pkCSM, a software used to predict the pharmacokinetic properties of small molecules using graph-based signatures was used to perform ADMET studies (Pires, Blundell, and Ascher 2015) . This tool requires the SMILES format of the ligand to be uploaded. For the compounds whose structures were available on PubChem, the SMILES format was taken from PubChem, while for those that were drawn on Marvin Sketch, the SMILES format was generated using the online SMILES translator by the National Institutes of Health (NIH) (https://cactus.nci.nih.gov/chemical/structure). The SMILES format was pasted onto the server, the prediction mode was set to "ADMET", and the prediction software gave us a comprehensive table of values of the absorption, distribution, metabolism, excretion, and toxicity of the uploaded compound. Drug likeness studies are performed to fulfil a set of guidelines that suggest whether the ligand can be considered as a drug-like compound, thus improving its chances of passing further clinical trials (Jia et al. 2020 (Schüttelkopf and Van Aalten 2004) and the protein parameters were generated using gromos54a7 force field. The cubic simulation box around the docked complex was built using the gmxeditconf tool. This processed system was vacuum minimized for 1500 steps using the steepest descent algorithm. Solvation was performed with SPC water model using gmx solvate tool and the system was electroneutralized using the gmxgenion tool (Gupta et al. 2020; Prasanth et al. 2020) . Energy minimization removes any steric clashes and further optimizes the structure. The next step is equilibration, which is performed in two steps. The first step consists of NVT equilibration, wherein the number of particles, volume and temperature are kept constant (Páll et al. 2015) . This was performed for 100 picoseconds and the system was kept at 300 K. In the second step, NPT equilibration was performed for 100 picoseconds. Each resultant structure was then run in NPT ensemble for 100ns simulation time (Krishna et al. 2021; Prasanth et al. 2020 ). Root Mean Square Deviation (RMSD) and Root Mean Square Fluctuations of the protein were calculated using gmx rms, and gmx rmsf tools respectively (Gupta et al. 2020) . gmx gyrate, gmx sasa and gmx hbond tools were used to calculate the radius of gyration, solvent accessible surface area, and the number of hydrogen bonds formed between protein and the ligand respectively Additionally, secondary structure analysis of the target protein was also examined for the entire simulation time. The Molecular Mechanics Poisson-Boltzmann surface area (MM-PBSA) approach combines three energetic terms: change in the potential energy in vacuum, desolvation of the different species and configurational entropy associated with complex formation in the gas phase, to account for the change in free energy on binding. A GROMACS utility g_mmpbsa was utilized to estimate the binding free energy (Kumari, Kumar, and Lynn 2014) . To improve the accuracy of our results, we found the ∆G binding for the last 20ns with respect to1000 frames Prasanth et al. 2020 ). The active site of 3Clpro/M Pro lies in the gap between domains I and II consisting of a Cys-His catalytic dyad (Cys145 and His41) (Wu et al., 2020a) . The active pocket consists of J o u r n a l P r e -p r o o f hydrophobic amino acids such as Tyr54, Met49, Met165, Phe140, Leu141, Cys145, Leu27, Pro168, Leu167, Cys145, Ala191, Cys44, Leu50 and Met40, which provide a relatively hydrophobic environment to contain the compound and stabilize its conformation. The cocrystallized structure of 3Clpro along with inhibitor N3 (PDB ID: 6LU7) was used to identify the other amino acids in and near the active site which contribute to the binding and stabilization of the ligands (Jin et al. 2020) . Of the top 10 compounds, Myricitrin (CID: 5352000) showed the highest binding affinity of -9.6 kcal/mol. Following myricitrin, Quercetin-3-O glucuronide isomer1 (CID: 12004528) showed the next highest binding affinity of -9.4 kcal/mol. The top 10 compounds with their binding affinities values are shown in Table 2 . Ellagic Acid-O-Arabinoside __ -9 Kaempferol-3-Orutinoside 122173234 -9 Isocorilagin 10077799 -9 Furosin 10416810 -9 Trigalloylglucose 452707 -9 Phyllanthusiin B ___ -8.9 Ritonavir 392622 -7 Lopinavir 92727 -6.8 active site. Table 3 shows the type of interactions as well as the residues with which they interact. Arg40 forms 3 hydrogen bonds with the oxygen groups in the glucose ring with Chemical absorption, distribution, metabolism, excretion and toxicity (ADMET) are five major properties that must be taken into consideration during drug discovery (Guan et al. 2019 ) . Prediction of ADMET properties plays an important role in the process of drug discovery as molecules with poor ADMET properties are what account for the failure of about 60% of all drugs in clinical trials. A good drug candidate is absorbed in the required time and well distributed throughout the system for its effective metabolism and action. Table 4 contains the results of the ADMET studies performed on the ten compounds. Of the ten finalized compounds, seven of them had excellent intestinal absorption, an important requirement for a drug since the intestine serves as the primary site of absorption of a drug that is taken orally (Elbager et al. 2020) . The water solubility of the compounds was quite low, but there are means to increase the solubility of a drug in water such as particle size reduction, nanosuspension and the use of surfactants (Sareen, Joseph, and Mathew 2012) . Of the ten compounds, six of them display high Caco2 permeability, including the top two compounds, an important attribute as this parameter is an in vitro model of the intestinal mucosa and helps predict the absorption of orally administered drugs. All of the compounds are substrates of P-glycoprotein, an efflux membrane transporter responsible for the distribution of xenobiotics. Isocorilagin was found to be a substrate and class I and II inhibitor of P-glycoprotein, making it more pharmacologically active than noninhibitors (M. L. Amin 2013). Of the ten compounds, six of them had a low VDss value, indicating that more of the compound would be distributed in the plasma rather than the tissue. The other four had moderate VDss values, possibly indicating that a more-or-less equal amount gets distributed in the tissue and the plasma. All of the compounds' fraction that remained unbound (and thus available to bind to 3ClPro) ranged from 0.048 to 0.383. None of the compounds are substrates of CYP2D6 or CYP3A4, and hence none of them are inhibitors of any of the CYP isoforms. All of the compounds have a high half-life in terms of total clearance, suggesting that they aren't rapidly cleared from the body (Berellini, Waters, and Lombardo 2012) . Eight out of the ten compounds are not substrates of renal OCT2. All of the compounds have low AMES toxicity, hepatotoxicity and minnow toxicity. All compounds are not hERG I inhibitors, while six of the ten compounds are not hERG II inhibitors. This reduces the risk of the development of ventricular arrhythmia. All compounds require a higher dose to cause the J o u r n a l P r e -p r o o f death of 50% of a group of test animals (Rat LD50). The only anomaly observed was that all compounds have a relatively high T. Pyriformis toxicity and thus, further in vitro and in vivo studies need to be done to assess the toxicity levels of the compounds. Lipinski's rule of five and Veber's rule were used to assess the drug-likeness of the compounds. Table 5 According to Veber's rule, TPSA must not exceed 140 angstroms for intestinal absorption (Lipinski 2005; N. Schneider et al. 2008; Vistoli et al. 2008 (Gillet, Willett, and Bradshaw 1998; Oprea 2000) . The of 100 ns. Myricitrin forms 6 hydrogen bonds for the majority of the 100ns timescale with the largest number was found to be 11. Quercetin-3-O-glucuronide isomer1 forms 4 hydrogen bonds for the majority of the 100ns timescale while 10 was found to be the highest ( Figure 3(b) ). This suggests that both compounds are strongly bound to 6LU7 with Myricitrin forming stronger bonds as compared to Quercetin-3-glucoronide for the majority of the timescale. The RMSF values of the ligand-protein complexes were calculated in order to understand the local fluctuations taking place, in turn, assessing the flexibility of the residues at structural subsets within the overall rigid structure of the protein1. For Quercetin-3glucoronide, an average of 0.221 nm was observed, with a highest of 0.5585 nm at Gly283. On average, higher fluctuations were observed with residues close to the binding pocket in the beginning because of the hydrophobic core being exposed to the aqueous environment. This is agreeable with the SASA values of the apo-protein as the highest value of 159.662 nm 2 (with an average of 148.77 nm 2 ) was observed within the first nanosecond. However, towards the end of the simulation, the lowest SASA value was observed (142.178 nm 2 at 99.830 ns for Quercetin-3-glucoronide and 135.564 nm 2 at 99.6 ns for Myricitrin), indicating that by the end of the simulation more of the ligand is buried into the protein, rather than interacting with the aqueous environment (Figure 3(d) ). This trend is seen with the apoprotein as well, as towards the end of the simulation, it too has its SASA values at the lower end of its range. Thus, we can conclude that the ligands interact satisfactorily with the active site of the protein due to the reduction in the SASA values. A plot of radius of gyration spanning over 100 ns is analysed in order to understand the overall dimension and shape of the protein (Yadav et al. 2018) . In order to get an overview of the RMSD values, a graph of probability distribution vs RMSD values was plotted (Figure 6(a) ). Here, we can clearly observe that the mean values of the RMSDs of both docked complexes are very close to each other (0.47 nm for Quercetin-3glucoronide and 0.50 nm for Myricitrin). However, the spread of data is more for Myricitrin, suggesting more fluctuations in the RMSD values, while for Quercetin-3-glucoronide, the J o u r n a l P r e -p r o o f spread of data is narrower, suggesting that this docked complex attains a more stable conformation during molecular dynamics simulations. The apo-protein has a mean RMSD of 0.248 nm, with a narrow spread of data, which according to its resolution of 2.16 Å, confirms the stability of this structure during simulation (Carugo 2003) . The probability distribution curves of the SASA values of both docked complexes along with the apo protein were plotted to provide a clearer display of the accessibility of the ligand to the protein during simulation (Figure 6(b) ). From the graph we can clearly see that the distribution curve of Myricitrin is slightly to the left to that of Quercetin-3-glucoronide. The apo-protein alone has a distribution similar to that of the complex with Myricitrin. This suggests that the hydrophobic core of 6LU7 is slightly more accessible to the aqueous environment around it when complexed with Quercetin-3-glucoronide, as suggested by a larger peak value of 152.807 nm. The protein, being more accessible to the aqueous environment, suggests that it is less accessible to the ligand. For Myricitrin, on the other hand, with a lower peak value of 148.823 nm, it can be inferred that the hydrophobic core is more protected from the external environment and thus, the protein is more accessible to the ligand. Since a majority of the distribution of the apo-protein and the docked complex with Myricitrin converge with each other, it can be inferred that the target that is docked with Myricitrin and the apo-protein itself undergo similar conformational changes, with respect to the area of the complex that is accessible to the surrounding aqueous environment, during the course of the simulation, confirming the stability of this docked complex. We observed that the difference between the RMSF values of the apo-protein and that of the two docked complexes at the active site regions were much lower than other regions, as pointed out by the graph. (Figure 7) . At the active site regions, the difference between the RMSF values were all less than 0.1 nm, which suggests that the fluctuations experienced between the protein and the complexes were relatively low, considering the base fluctuations that the apo-protein itself experiences. This further confirms the stability of the docked complexes during the course of the simulation The secondary structural features of 6LU7 in its wild form, and the evolution of the apo form on binding to ligands MYR and QUE respectively are depicted in Figure 8 . The apo protein has the triple helix secondary structure feature in the 40-60 aa residue range, but on J o u r n a l P r e -p r o o f the formation of the 6LU7-MYR and 6LU7-QUE complexes, there was an interruption in this distribution and the triple helices are replaced with bends. A similar trend of loss of certain secondary structural features was noticed in the 120-140 range where bends replaced most of the beta turns in case of 6LU7-MYR, but 6LU7-QUE found randomly distributed beta bridges, bends, beta turns, alpha helices and triple helices in place of beat turns. Residues 140-160 showed a loss of beta turns in 6LU7-MYR and 6LU7-QUE; instead, more beta bridges and beta sheets, bends, alpha and triple helices were found in that region in the complexes respectively. More such differences were found in the 300+ residues range, with loss in alpha helices on binding of the ligands. It can hence be concluded that the binding of MYR and QUE ligands to the 6LU7 protein induced minor conformational changes in it, leading to alterations in the structural integrity for forming stable complexes and the results were consistent with the other structural parameters of molecular dynamics simulations analysed. Molecular mechanics energies with Poisson-Boltzmann surface area continuum solvation, simply put as MMPBSA, is a method for the estimation of free energy that comes into play when small ligands bind to biological macromolecules (Genheden and Ryde 2015) . Estimations done by MMPBSA were found to be more accurate than most scoring functions, and hence are widely used in the fields of drug design and other research aspects. The MMPBSA method is optimized by values from protein-ligand systems, and the binding energy is the sum of the values of van der Waal energy, electrostatic energy, polar solvation energy and SASA energy. The van der Waal interactions were found to play a major role in the binding energy calculation and promotion of protein-ligand binding, hence is considered a breakthrough point in drug development (K. J o u r n a l P r e -p r o o f antimicrobial properties, based on in vitro zone of inhibition assays (Sham Bhat et al. 2015) . It has also shown anti-viral activity against dengue virus, with more that 90% viral reduction in vitro, and it was also found that the cocktail of different Phyllanthus species (including Phyllanthus amarus) showed low toxicity to Vero cells (S. H. Lee et al. 2013) . Phyllanthus amarus extracts have also been studied on the level of the immune system, where the various phytochemicals were proven to have immunomodulatory effects, thus emphasizing their potential to be developed into standardized immunomodulatory agents (Yuandani et al. 2013 ). Both Myricitrin and Quercetin-3-glucoronide fall under the class of flavonoids, which could be argued to be the richest source of antivirals in the entire plant kingdom (Fleischer and Laessig 2003) . Myricitrin, also known as myricetin-3-O-rhamnoside, has shown antiviral activity against the H1N1 influenza virus (K.E. Motlhatlego et al. 2018) , in vitro anti-HBV activity (Parvez et al. 2020 ) as well as in vitro anti-HIV-1 activity (Pasetto, Pardi, and Murata 2014) . Myricitrin has been shown to be a potential HA-inhibitor drug in a study on the effect of Myricitrin against H1N1 influenza virus, where it showed excellent abilities to both a prophylactic as well as a treatment option (Katlego E. Motlhatlego et al. 2021 ). In addition to this, it was also observed that Myricitrin was non-toxic at high concentrations. In another study, Myricitrin was shown to have anti-African Swine Flu Virus (ASFV) protease activity, confirming its activity against viral proteases (Jo et al. 2020) . Myricitrin has also proven to bind with high affinity to TMPRSS2, a protein that plays an important role in viral entry into cells (Chikhale et al. 2020 ). Quercetin, from which Quercetin-3-glucoronide is derived, has shown anti-viral affects against influenza A virus (Choi et al. 2009 ) and anti-HBV activity (Cheng et al. 2015) . Quercetin-3-O-glucoronide has been studied against the influenza A virus. One study focused on in silico screening and found that Quercetin-3-Oglucoronide bound with high affinity to the polymerase basic 2 subunit of RNA polymerase J o u r n a l P r e -p r o o f (Gansukh et al. 2021) . Another study conducted in vivo experiments in mice to test against influenza A virus, where it was found that it could supress ear edema, peritoneal permeability by acetic acid as well as lung edema induced by the influenza A virus (Fan et al. 2011) . With their anti-viral activity already established, these two compounds can perhaps be potential inhibitors of the SARS-CoV-2 virus as well, as confirmed by the high binding affinity values in our study. J o u r n a l P r e -p r o o f The COVID-19 pandemic is a fight that still needs to be fought by humanity and apart from prevention by vaccination, the only way out is through the discovery of novel drugs. Our study has identified some lead compounds from Phyllanthus amarus that may be used for the inhibition of 3ClPro in COVID-19. Molecular docking studies confirmed the binding of the compounds at the active site of this protease. Of the 190 phytochemicals that were docked with 3ClPro, the top 16 compounds showed excelled binding affinity with values between -8.9 kcal/mol and -9.6 kcal/mol. Of these, the top two compounds with highest binding affinity and favourable binding interactions, Myricitrin and Quercetin-3-glucoronide, were further chosen for molecular dynamics simulations and the 100 ns simulation revealed that the protein-ligand complexes possessed stable conformations. ADMET studies revealed that J o u r n a l P r e -p r o o f most of the compounds had good absorption properties and low acute toxicity values, with the only outlier being T. Pyriformis toxicity. In conclusion, this study brings out the importance of natural products in the drug discovery process, specifically phytochemicals from Phyllanthus amarus. We propose the usage of whole Phyllanthus amarus extract in our fight against COVID-19. Further in vitro and in vivo studies need to be conducted in order to reaffirm our findings as therapeutics for the human coronavirus, SARS-CoV-2. The authors declare that they have no conflict of interest. P-Glycoprotein Inhibition for Optimal Drug Delivery Fight against Novel Coronavirus: A Perspective of Medicinal Chemists 45 ajol.info ANTIPLASMODIAL ACTIVITY OF EXTRACTS OF TRIDAX PROCUMBENS AND PHYLLANTHUS AMARUS IN IN VITRO PLASMODIUM FALCIPARUM CULTURE SYSTEMS BDDCS, the Rule of 5 and Drugability In Silico Prediction of Total Human Plasma Clearance The Protein Data Bank A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 How Root-Mean-Square Distance (r.m.s.d.) Values Depend on the Resolution of Protein Structures That Are Compared Molecular Docking, Molecular Dynamics Simulation, Biological Evaluation and 2D QSAR Analysis of Flavonoids from Syzygium Alternifolium as Potent Anti-Helicobacter Pylori Agents Inhibition of Hepatitis B Virus Replication by Quercetin in Human Hepatoma Cell Lines Identification of Potential Anti-TMPRSS2 Natural Products through Homology Modelling, Virtual Screening and Molecular Dynamics Simulation Studies Inhibitory Effects of Quercetin 3-Rhamnoside on Influenza A Virus Replication Small-Molecule Library Screening by Docking with PyRx Computational Methods for the Prediction of Protein Folds Preliminary Phytochemical Investigation and Antibacterial Activity of Phyllanthus Amarus Schum & Thorn Drug Repurposing and Orphan Disease Therapeutics An Interactive Web-Based Dashboard to Track COVID-19 in Real Time Polyprotein Cleavage Mechanism of SARS CoV M pro and Chemical Modification of the Octapeptide Toxicological Survey of African Medicinal Plants Toxicological Survey of African Medicinal Plants Molecular Dynamics Simulations of Wild-Type and Point Mutation Human Prion Protein at Normal and Elevated Temperature Identification of Potential Drug Targets and Prediction of the Potential Impact of High Risk Non Synonymous Single Nucleotide Polymorphism in SARS-CoV-2 3C like Proteinase (3CLpro): A Computational Approach Anti-Inflammatory, Antiviral and Quantitative Study of Quercetin-3-O-β-D-Glucuronide in Polygonum Perfoliatum L Safety and Efficacy Evaluation of Pleconaril for Treatment of the Common Cold New Insights into Antiviral and Cytotoxic Potential of Quercetin and Its Derivatives -A Biochemical Perspective Structure of the RNA-Dependent RNA Polymerase from COVID-19 Virus The MM/PBSA and MM/GBSA Methods to Estimate Ligand-Binding Affinities Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics COVID-19: Drug Targets and Potential Treatments Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms ADMET-Score-a Comprehensive Scoring Function for Evaluation of Chemical Drug-Likeness SWISS-MODEL and the Swiss-PdbViewer: An Environment for Comparative Protein Modeling Identification of Potential Natural Inhibitors of SARS-CoV2 Main Protease by Molecular Docking and Simulation Studies The Novel Coronavirus: A Bird's Eye View Anti-Inflammatory Effects of Phyllanthus Amarus Schum. & Thonn. Through Inhibition of NF-ΚB, MAPK, and PI3K-Akt Signaling Pathways in LPS-Induced Human Macrophages Conservation of Substrate Specificities among Coronavirus Main Proteases Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China An Accurate Free Energy Estimator: Based on MM/PBSA Combined with Interaction Entropy for Protein-Ligand Binding Affinity Pharmacokinetic Properties of Biomass-Extracted Substances Isolated by Green Solvents Phylogenetic Analysis and Structural Modeling of SARS-CoV-2 Spike Protein Reveals an Evolutionary Distinct and Proteolytically Sensitive Activation Loop Plants Used for the Treatment of Icterus (Jaundice) in Central India: A Review A Drug-Likeness Toolbox Facilitates ADMET Study in Drug Discovery Structure of M pro from SARS-CoV-2 and Discovery of Its Inhibitors Inhibition of African Swine Fever Virus Protease by Myricetin and Myricitrin Structure-Based Design Approach of Potential Bcl-2 Inhibitors for Cancer Chemotherapy In Silico Screening of Therapeutic Potentials from Strychnos Nux-Vomica against the Dimeric Main Protease (Mpro) Structure of SARS-CoV-2 G-Mmpbsa -A GROMACS Tool for High-Throughput MM-PBSA Calculations Phyllanthus Amarus Down-Regulates Hepatitis B Virus MRNA Transcription and Replication Effects of Cocktail of Four Local Malaysian Medicinal Plants (Phyllanthus Spp.) against Dengue Virus 2 Identification of Natural Compounds with Antiviral Activities against SARS-Associated Coronavirus Antioxidant Properties of Phyllanthus Amarus Extracts as Affected by Different Drying Methods Capter 11 Filtering in Drug Discovery The Genus Phyllanthus: An Ethnopharmacological, Phytochemical, and Pharmacological Review Software News and Updates AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility International Journal of Pharmacognosy A Study of the Effect of Phyllanthus Amarus Extracts on Blood Glucose in Rabbits Antiviral Activity against Influenza H1N1 Virus of Myricetin-3-O-Rhamnoside Isolated from Newtonia Buchananii and Its Mechanism of Action Anti-Influenza A Virus Activity of Two Newtonia J o u r n a l P r e -p r o o f Species and the Isolated Compound Myricetin-3-o-Rhamnoside Antiviral Potentials of Medicinal Plants Insights into SARS-CoV-2 Genome, Structure, Evolution, Pathogenesis and Therapies: Structural Genomics Approach Design Principles for Quadruplex-Binding Small Molecules Drug-Likeness' Properties of Natural Compounds Impact of Generic Antimalarial or Phyllanthus Amarus and Vitamin Co-Administration on Antioxidant Status of Experimental Mice Infested with Plasmodium Berghei Property Distribution of Drug-Related Chemical Databases Tackling Exascale Software Challenges in Molecular Dynamics Simulations with GROMACS Inhibitory Potential of Neem (Azadirachta Indica Juss) Leaves on Dengue Virus Type-2 Replication Bioassay-Guided Isolation of Anti-Hepatitis B Virus Flavonoid Myricetin-3-O-Rhamnoside along with Quercetin from Guiera Senegalensis Leaves Anti-HIV-1 Activity of Flavonoid Myricetin on HIV-1 Infection in a Dual-Chamber In Vitro Model Phyllanthus Amarus: Ethnomedicinal Uses, Phytochemistry and Pharmacology: A Review Molecular Dynamics Simulations of Wild Type and Mutants of SAPAP in Complexed with Shank3 PkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures In Silico Identification of Potential Inhibitors from Cinnamon against Main Protease and Spike Glycoprotein of SARS CoV-2 Complete Thermodynamic Description of HÅBonding in the Framework of 81 Journal of Ethnopharmacology Antitumour and Anticarcinogenic Activity of Phyllanthus Amarus Extract Cite This Paper Antitumour and Anticarcinogenic Activity of Phyllanthus Amarus Extract PubChem 2019 Update: Improved Access to Chemical Data Preparation and Anti-HIV Activities of Retrojusticidin B Analogs and Azalignans Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review Improvement in Solubility of Poor Water-Soluble Drugs by Solid Dispersion An Overview of Important Ethnomedicinal Herbs of Phyllanthus Species: Present Status and Future Prospects Prediction of Drug-like Properties Gradual in Silico Filtering for Druglike Substances PRODRG: A Tool for High Throughput Crystallography of Protein-Ligand Complexes Preclinical Screening of Phyllanthus Amarus Ethanolic Extract for Its Analgesic and Antimicrobial Activity Hypoglycemic Activity of Ethanolic Leaf Extract of Phyllanthus Amarus in Alloxan Induced Diabetic Mice Structural and Molecular Basis of the Interaction Mechanism of Selected Drugs towards Multiple Targets of SARS-CoV-2 by Molecular Docking and Dynamic Simulation Studies-Deciphering the Scope of Repurposed Drugs Statement on the Second Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Novel Coronavirus (2019-NCoV) The SARS-CoV-2 Main Protease as Drug Target 84 Proc. Nati. Acad. Sci. USA Effects of an Extract from Phyllanthus Niruri on Hepatitis B and Woodchuck Hepatitis Viruses: In Vitro and in Vivo Studies (Antiviral Agent/Marmota Monax/DNA Polymerase/Hepatitis B Surface Antigen/Woodchuck Hepatitis Surface Antigen) Assessing Drug-Likeness-What Are We Missing? Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach to Enable Alignment of Druglike Properties Remdesivir in Adults with Severe COVID-19 : A Randomised Double-Blind, Placebo-Controlled, Multicentre Trial A New Coronavirus Associated with Human Respiratory Disease in China Clonal Propagation of Phyllanthus Amarus: A Hepatoprotector Pyran Analogs with SIRT6/COX-2: A Molecular Dynamics Study The in Vitro Activity of Geraniin and 1,3,4,6-Tetra-O-Galloylβ-d-Glucose Isolated from Phyllanthus Urinaria against Herpes Simplex Virus Type 1 and Type 2 Infection Inhibitory Effects of Standardized Extracts of Phyllanthus Amarus and Phyllanthus Urinaria and Their Marker Compounds on Phagocytic Activity of Human Neutrophils The Crystal Structure of COVID-19 Main Protease in Apo Form Crystal Structure of SARS-CoV-2 Main Protease Provides a Basis for Design of Improved a-Ketoamide Inhibitors CHEMICAL CONSTITUENTS AND ANTIMICROBIAL PROPERTIES OF Phyllanthus Amarus (SCHUM & THONN) The authors thank the management, M S Ramaiah Institute of Technology, for providing necessary computational facilities and support. ☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.☐The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Krishna Murthy T P J o u r n a l P r e -p r o o f